NEA Management Company’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $11.5M | Sell |
|
|||||
|
2023
Q4 | $11.2M | Hold |
|
|||||
|
2023
Q3 | $7.15M | Hold |
|
|||||
|
2023
Q2 | $8.29M | Hold |
|
|||||
|
2023
Q1 | $6M | Sell |
|
|||||
|
2022
Q4 | $27.2M | Sell |
|
|||||
|
2022
Q3 | $5.01M | Hold |
|
|||||
|
2022
Q2 | $5.43M | Hold |
|
|||||
|
2022
Q1 | $10.4M | Hold |
|
|||||
|
2021
Q4 | $13.1M | Hold |
|
|||||
|
2021
Q3 | $19.9M | Hold |
|
|||||
|
2021
Q2 | $21.1M | Hold |
|
|||||
|
2021
Q1 | $27.4M | Hold |
|
|||||
|
2020
Q4 | $34.2M | Hold |
|
|||||
|
2020
Q3 | $27.9M | Hold |
|
|||||
|
2020
Q2 | $34.2M | Hold |
|
|||||
|
2020
Q1 | $20.7M | Hold |
|
|||||
|
2019
Q4 | $48.1M | Hold |
|
|||||
|
2019
Q3 | $39.2M | Hold |
|
|||||
|
2019
Q2 | $108M | Hold |
|
|||||
|
2019
Q1 | $113M | Hold |
|
|||||
|
2018
Q4 | $86.1M | Hold |
|
|||||
|
2018
Q3 | $131M | Hold |
|
|||||
|
2018
Q2 | $147M | Buy |
|
|||||
|
2018
Q1 | $139M | Hold |
|
|||||
|
2017
Q4 | $144M | Hold |
|
|||||
|
2017
Q3 | $120M | Hold |
|
|||||
|
2017
Q2 | $95.8M | Hold |
|
|||||
|
2017
Q1 | $46.6M | Hold |
|
|||||
|
2016
Q4 | $52.4M | Hold |
|
|||||
|
2016
Q3 | $61.4M | Hold |
|
|||||
|
2016
Q2 | $62.4M | Hold |
|
|||||
|
2016
Q1 | $51.2M | Hold |
|
|||||
|
2015
Q4 | $49.1M | Buy |
|
|||||
|
2015
Q3 | $48M | Hold |
|
|||||
|
2015
Q2 | $68.2M | Hold |
|
|||||
|
2015
Q1 | $71.3M | Hold |
|
|||||
|
2014
Q4 | $61.7M | Hold |
|
|||||
|
2014
Q3 | $59.5M | Hold |
|
|||||
|
2014
Q2 | $72.3M | Hold |
|
|||||
|
2014
Q1 | $140M | Buy |
|